Cochrane Abstracts
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Addition of Long-acting Beta2-agonists to Inhaled Steroids Versus Higher Dose Inhaled Steroids in Adults and Children With Persistent Asthma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433210/all/Addition_of_long_acting_beta2_agonists_to_inhaled_steroids_versus_higher_dose_inhaled_steroids_in_adults_and_children_with_persistent_asthma:_Cochrane_systematic_review. Accessed 25 January 2021.
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/all/Addition_of_long_acting_beta2_agonists_to_inhaled_steroids_versus_higher_dose_inhaled_steroids_in_adults_and_children_with_persistent_asthma:_Cochrane_systematic_review. Accessed January 25, 2021.
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review. In Cochrane Abstracts Retrieved January 25, 2021, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/all/Addition_of_long_acting_beta2_agonists_to_inhaled_steroids_versus_higher_dose_inhaled_steroids_in_adults_and_children_with_persistent_asthma:_Cochrane_systematic_review
Addition of Long-acting Beta2-agonists to Inhaled Steroids Versus Higher Dose Inhaled Steroids in Adults and Children With Persistent Asthma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 January 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/all/Addition_of_long_acting_beta2_agonists_to_inhaled_steroids_versus_higher_dose_inhaled_steroids_in_adults_and_children_with_persistent_asthma:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review
ID - 433210
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/all/Addition_of_long_acting_beta2_agonists_to_inhaled_steroids_versus_higher_dose_inhaled_steroids_in_adults_and_children_with_persistent_asthma:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
